Mj Biotech, Inc. (MJTV) SEC Filing 8-K Material Event for the period ending Tuesday, October 23, 2018

Mj Biotech, Inc.

CIK: 1543272 Ticker: MJTV

View differences made from one to another to evaluate Mj Biotech, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Mj Biotech, Inc..


Assess how Mj Biotech, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Mj Biotech, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Mj Biotech, Inc. provided additional information to their SEC Filing as exhibits

Ticker: MJTV
CIK: 1543272
Form Type: 8-K Corporate News
Accession Number: 0001543272-18-000028
Submitted to the SEC: Thu Oct 25 2018 2:35:48 PM EST
Accepted by the SEC: Thu Oct 25 2018
Period: Tuesday, October 23, 2018
Industry: Computer Programming Data Processing
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: